Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a phone app help end HIV stigma and boost prevention?

NCT ID NCT07509827

Prevention Sponsor: Institute of HIV Research and Innovation Foundation, Thailand Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a mobile health program designed to reduce HIV-related stigma and improve use of PrEP (a daily pill that prevents HIV) among young transgender women in Thailand. The program includes counseling and stigma-reduction activities delivered via smartphone. Researchers will enroll 108 HIV-negative transgender women aged 18-29 who are not currently using PrEP or are not taking it regularly.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
mobile health program (Mobile Healthy Choices and FRESH) plus standard PrEP counseling
What this could lead to
If successful, this could provide an effective way to reduce HIV stigma and increase PrEP use among young transgender women.
What could go wrong
This is a small, early-stage study with 108 participants, so results may not apply broadly. The intervention relies on self-reported adherence, which can be unreliable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 108 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2024

Expected to finish

Jul 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 29 years

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18-29 years * Male sex at birth * Self-identify as transgender woman/female spectrum * HIV-negative (laboratory confirmed) * Recent condomless sex * Able to understand Thai * Not on PrEP or poorly adherent (≤3 pills/week) Exclusion Criteria: * Serious cognitive or psychiatric condition affecting consent * Active suicidal ideation or major mental illness * Medical contraindications to PrEP * Enrolled in another HIV intervention study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV prevention are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV prevention HIV-related stigma Prep adherence

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Institute of HIV Research and Innovation (IHRI)

    RECRUITING

    Bangkok, Pathumwan, 10330, Thailand

  • Rainbow Sky Association of Thailand (RSAT)

    RECRUITING

    Bangkok, Bangkapi, 10240, Thailand

  • The Service Workers In Group Foundation (SWING)

    RECRUITING

    Bangkok, Building 3, Patpong, Surawong Road, 10500, Thailand

More trials for these conditions

Other studies related to the condition(s) this trial covers.